Familial Hypercholesterolemia in South Africa

South Africa, especially the Caucasian part of the population, has one of the highest incidences of familial hypercholesterolemia in the world. The founder effect in this region has led to this high incidence and to a limited number of mutations in the low-density lipoprotein-receptor gene. This chapter describes current situation concerning the management of familial hypercholesterolemia in South Africa.

KEYWORDS

Familial hypercholesterolemia - cardiovascular disease - homozygous FH - South Africa

REFERENCES

• 1 Brown M S, Dana S E, Goldstein J L. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia.  J Biol Chem. 1974;  249 789-796
• 2 Seftel H C, Baker S G, Sandler M P et al.. A host of hypercholesterolaemic homozygotes in South Africa.  BMJ. 1980;  281 633-636
• 3 Van der Westhuyzen D R, Coetzee G A, Demasius I P et al.. Low density lipoprotein receptor mutations in South African homozygous familial hypercholesterolemic patients.  Arteriosclerosis. 1984;  4 238-247
• 4 Coetzee G A, Van der Westhuyzen D R, Berger G M, Henderson H E, Gevers W. Low density lipoprotein metabolism in cultured fibroblasts from a new group of patients presenting clinically with homozygous familial hypercholesterolemia.  Arteriosclerosis. 1982;  2 303-311
• 5 Rubinsztein D C, Jialal I, Leitersdorf E, Coetzee G A, van der Westhuyzen D R. Identification of two new LDL-receptor mutations causing homozygous familial hypercholesterolemia in a South African of Indian origin.  Biochim Biophys Acta. 1993;  1182 75-82
• 6 Kotze M J, Langenhoven E, Warnich L et al.. The identification of two low-density lipoprotein receptor gene mutations in South African familial hypercholesterolaemia.  S Afr Med J. 1989;  76 399-401
• 7 Leitersdorf E, Van der Westhuyzen D R, Coetzee G A, Hobbs H H. Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners.  J Clin Invest. 1989;  84 954-961
• 8 Gevers W. Three mutations that cause familial hypercholesterolemia in Afrikaners identified-a milestone in South African medicine.  S Afr Med J. 1989;  76 393-394
• 9 Rubinsztein D C, van der Westhuyzen D R, Coetzee G A. Monogenic primary hypercholesterolaemia in South Africa.  S Afr Med J. 1994;  84 339-344
• 10 Rubinsztein D C, Coetzee G A, Van der Westhuyzen D R, Langenhoven E, Kotze M J. Familial defective apolipoprotein-B is rare in hypercholesterolaemic South African Afrikaners, coloureds and Indians.  S Afr Med J. 1995;  85 355-357
• 11 Rubinsztein D C, Raal F J, Seftel H C et al.. Characterization of six patients who are double heterozygotes for familial hypercholesterolemia and familial defective apo B-100.  Arterioscler Thromb. 1993;  13 1076-1081
• 12 Steyn K, Goldberg Y P, Kotze M J et al.. Estimation of the prevalence of familial hypercholesterolaemia in a rural Afrikaner community by direct screening for three Afrikaner founder low density lipoprotein receptor gene mutations.  Hum Genet. 1996;  98 479-484
• 13 Seftel H C, Baker S G, Jenkins T, Mendelsohn D. Prevalence of familial hypercholesterolemia in Johannesburg Jews.  Am J Med Genet. 1989;  34 545-547
• 14 Graadt van Roggen F, Van der Westhuyzen D R, Marais A D, Gevers W, Coetzee G A. Low density lipoprotein receptor founder mutations in Afrikaner familial hypercholesterolaemic patients: a comparison of two geographical areas.  Hum Genet. 1991;  88 204-208
• 15 Berger G M, Miller J L, Bonnici F, Joffe H S, Dubovsky D W. Continuous flow plasma exchange in the treatment of homozygous familial hypercholesterolemia.  Am J Med. 1978;  65 243-251
• 16 Forman M B, Baker S G, Mieny C J et al.. Treatment of homozygous familial hypercholesterolaemia with portacaval shunt.  Atherosclerosis. 1982;  41 349-361
• 17 Marais A D, Naoumova R P, Firth J C et al.. Decreased production of low density lipoprotein by atorvastatin after apheresis in homozygous familial hypercholesterolemia.  J Lipid Res. 1997;  38 2071-2078
• 18 Raal F J, Pilcher G J, Illingworth D R et al.. Expanded-dose simvastatin is effective in homozygous familial hypercholesterolaemia.  Atherosclerosis. 1997;  135 249-256
• 19 Gevers W, Casciola L A, Fourie A M et al.. Defective LDL receptors that are common in a large population. Familial hypercholesterolaemia in South Africa.  Biol Chem Hoppe Seyler. 1987;  368 1233-1243
• 20 Williams R R, Hamilton-Craig I, Kostner G M et al.. MEDPED: An integrated genetic strategy for preventing early deaths. In: Berg K, Boulyjenkov V, Christen Y Genetic Approaches to Noncommunicable Diseases. Berlin; Springer 1996: 35-45